Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from BioSpace

12:35 EST 21st February 2018 | BioPortfolio

Here are the most relevant search results for "BioSpace" found in our extensive news archives from over 250 global news sources.

More Information about BioSpace on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioSpace for you to read. Along with our medical data and news we also list BioSpace Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioSpace Companies for you to search.

Showing News Articles 1–25 of 11,000+ from BioSpace

Tuesday 20th February 2018

FDA Grants Evofem Biosciences’ Amphora Fast Track Designation

The U.S. Food and Drug Administration (FDA) granted San Diego-based Evofem Biosciences Fast Track designation for Amphora vaginal gel to prevent urogenital chlamydia infection in women.

Monday 19th February 2018

Aimmune Jumps On Phase III Peanut Allergy Trial Data

Aimmune Therapeutics announced late-stage trial results that showed its peanut allergy therapy was effective in more than 67 percent of juvenile patients.

Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B

Dynavax announced it has secured a $175 million non-dilutive term loan agreement to commercialize Heplisav-B.

AbbVie and Voyager Therapeutics Launch $1.2 Billion+ Alzheimer’s Partnership

AbbVie and Voyager Therapeutics inked a collaboration deal to develop treatments for Alzheimer’s disease and other neurodegenerative diseases.

J&J Could Explore Potential $2B Sale of Sterilization Products Division

Life sciences giant Johnson & Johnson may be shopping around its sterilization products division.

Federal Court Overturns Gilead Sciences and Merck Patent Dispute

Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision.

FDA Gives AstraZeneca’s Imfinzi the Nod for New Lung Cancer Indication

The U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Imfinzi to treat patients with unresectable Stage III non-small cell lung cancer (NSCLC).

PDL BioPharma Gives Up on Acquiring Neos Therapeutics

Nevada-based PDL BioPharma, Inc. said it will no longer pursue a proposed acquisition of Neos Therapeutics.

Sunday 18th February 2018

Analysts Split Over Buffett’s Backing of Teva Pharma

Some analysts are scratching their head over Warren Buffet's investment in Teva Pharma.

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçe...

RELIEF™ trial demonstrated statistically significant reductions in oral ulcers with apremilast 30 mg versus placebo through week 12.

AbbVie Presents New Phase 2b Data on Upadacitinib in Atopic Dermatitis

AbbVie today presented new positive results from a Phase 2b dose-ranging study evaluating upadacitinib, an investigational, once-daily oral JAK1-selective inhibitor, in adult patients with moderate to severe atopic dermatitis.

AbbVie Presents New Positive Late-Breaking Data from Two Phase 3 Psoriasis Trials of Risankizumab...

AbbVie presented today new positive results from the pivotal Phase 3 ultIMMa-1 and ultIMMa-2 replicate clinical trials that evaluated the safety and efficacy of risankizumab (150 mg) compared to placebo or ustekinumab (45 or 90 mg, based on patient weight).

3 Top Biotech Stocks to Consider in February

Analysts with The Motley Fool looked at three biotech stocks that even biotech-leery investors might consider.

FDA Makes Changes to Alzheimer’s Clinical Trial Goals Amidst Recent Failures

Despite the recent dismal news regarding Alzheimer’s drug development, the U.S. Food and Drug Administration (FDA) recently proposed new guidelines for developing drugs for the disease.

3 Biotech Stocks That Soared Recently

Three biotech stocks gained over 25 percent last week.

Report: Novartis Could Put Sandoz on the Auction Block Within a Few Weeks

Novartis may soon be looking to sell off its generics subsidiary Sandoz.

Eli Lilly and Hanmi Shutter a Failed Phase II RA Trial

Eli Lilly and its Korean collaborative partner Hanmi stopped a Phase II trial on an experimental rheumatoid arthritis treatment following less-than-stellar interim results.

Friday 16th February 2018

US FDA Approves Imfinzi® (Durvalumab) For Unresectable Stage III Non-Small Cell Lung Cancer

IMFINZI is the only immunotherapy approved for patients with unresectable Stage III non-small cell lung cancer.

Thursday 15th February 2018

Illumina Leaves Mission Bay for New Campus in the Peninsula

The new campus will consolidate some 400 employees in one place and give more space to the startup companies it helps.

Russia Allegedly Behind Merck's Cyberattack Last Year

Government officials say they are now certain they know who launched the NotPetya cyberwar that slammed operations at Merck last year.

Why Novavax Could be a Millionaire-Maker Stock

Novavax is hot right now -- but just how much hotter could this biotech stock get?

Amag Investors Cheer as Biotech Wins Second Drug Approval This Month

Makena was approved by the FDA in February 2011 and remains the first and only FDA-approved treatment option currently available for pregnant women who have had a prior spontaneous preterm birth.

FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros

The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form.

Officials Eye New Biotech Tenants for Bristol-Myers' Former Connecticut Complex

The 915,000-square-foot facility on Research Parkway was purchased this week by Calare Properties.

Drug Giant Roche Buys Former Google Execs' Flatiron in $1.9B Deal

Roche will plunk down $1.9M to acquire Flatiron Health, which has previously been backed by GV, as well as Roche.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks